Status:
RECRUITING
Reach Through Equitable Implementation in Utah
Lead Sponsor:
University of Utah
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Tobacco Use Cessation
Tobacco Use
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this pragmatic, multilevel Type III Hybrid Effectiveness-Implementation trial is to increase the reach of existing evidence-based interventions (EBIs) for tobacco cessation and to mitigate...
Detailed Description
REI-UT is a pragmatic, multilevel Type III Hybrid Effectiveness-Implementation trial with a 2x2x5 factorial experimental design. It consists of clinic level implementation strategies (AAC - SDOH, AAC ...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- Speak English or Spanish
- Currently use tobacco
- Live in a persistent poverty census tract
- Present at participating clinics
- Valid cell phone number in the electronic health record (EHR)
- Electronic health records indicate they have not opted out of receiving text contact from the clinic
Exclusion
- Opt-out of study
Key Trial Info
Start Date :
February 13 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2028
Estimated Enrollment :
1560 Patients enrolled
Trial Details
Trial ID
NCT06881069
Start Date
February 13 2025
End Date
January 30 2028
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah, United States, 84112